The effect of guideline-concordant novel therapy use on meeting cost targets in OCM: Results from a large community oncology network.

Stephen M. Schleicher,Basit Chaudhry,Christopher A. Waynick,Cheryl A. Crouse,Johnathan D. Shipley,Natalie R. Dickson,Jeffrey Patton,Susanna N. Supalla,Daniel Soudek,Aaron J. Lyss

The effect of guideline-concordant novel therapy use on meeting cost targets in OCM: Results from a large community oncology network.

2019

Stephen M. Schleicher
Basit Chaudhry
Christopher A. Waynick
Cheryl A. Crouse
Johnathan D. Shipley
Natalie R. Dickson
Jeffrey Patton
Susanna N. Supalla
Daniel Soudek
Aaron J. Lyss

6635Background: The Oncology Care Model (OCM) is intended to incentivize physicians to improve the quality and reduce the cost of cancer care. In OCM, providers are accountable for all costs during...

Keywords:

Medical physics
Guideline
Physical therapy
Medicine
Oncology
Internal medicine
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations